Gareth Probert

Partner, UK and European Patent Attorney, UPC Representative
London
gprobert@eip.com
Patenting
Patenting
UPC
UPC
Consulting
Consulting

Biography

Gareth is highly skilled in contentious IP having represented clients in many Opposition and Appeal hearings at all levels of the European Patent Office. Gareth is well placed to advise clients on the Unified Patent Court (UPC).

For the last 10 years Gareth has held senior positions at two leading IP firms. He is now the head of the EIP HealthTech practice group protecting innovations in the medtech and healthcare sectors. In addition, his practice covers food and fragrance technologies and the crossover area of chemistry and biotech.

Gareth has a track record of success in high-value difficult cases, including in several oppositions which were carried out in conjunction with parallel litigation proceedings. During his 20-year career in the profession Gareth has gained substantial experience in medtech and healthcare, in particular the FMCG, formulation, peptide, food and chemical sectors. He is a member of the CIPA Life Sciences Committee and the FICPI UK Council.

Gareth has a PhD in Synthesis using Zirconocene and a degree in Chemistry and Organic Chemistry, both from Southampton University.

Recent Work
Publications
Education
  • PhD Synthesis using Zirconocene - Southampton University (1993 — 1996)
  • BSc Chemistry and Organic Chemistry - Southampton University (1989 — 1993)
Languages Spoken
Career History
  • Partner at EIP (2020 — present)
  • Partner at HGF (2018 — 2020)
  • Partner at Potter Clarkson (2010 — 2017)
  • Associate and Senior Associate at Potter Clarkson (2004 — 2009)
  • Associate at WP Thompson (2002 — 2004)
  • Assistant at Forresters (1999 — 2002)
  • Synthetic Organic Chemist at Tocris (1996 — 1998)
Specialisms
  • Digital: Additive manufacturing, Digital health, Fintech, Semiconductors, Telemedicine and remote surgery
  • Dynamics: Additive manufacturing
  • Elements: Cosmetics & fragrances, Food & flavour ingredients, Pharmaceuticals, Polymers, Semiconductors
  • HealthTech: Additive manufacturing, Digital health, Femtech, Medical devices, Personalised healthcare, Surgical tools and implants, Telemedicine and remote surgery
  • Life: Agritech, Pharmaceuticals

The latest from

Gareth Probert

Make your bio(pharma) IP investment ready
22 March 2026
This recap of LinkedIn Live series focuses on helping (bio)pharma businesses make their IP investment‑ready. Across three sessions, experts will discuss building resilient IP portfolios, making strategic IP decisions ahead of funding rounds, and what the evolving 2026 (bio)pharma landscape means for long‑term IP strategy.

Contact us

Please complete the form below and we will be in touch shortly.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form. Please try again.